Σελίδες

Σάββατο 29 Αυγούστου 2015

PRP σε ρήξη αχίλλειου τένοντα.

O Δρ. Lawrence Gorfine στο κανάλι WPBF25 επιδεικνύει και εξηγεί την θεραπεία με PRP σε ασθενή πάσχουσα από ρήξη αχίλλειου τένοντα.

Τετάρτη 19 Αυγούστου 2015

Θεραπεία της οστεοαρθρίτιδας μέσο βλαστοκυττάρων από συμπύκνωμα μυελού οστών (BMAC).

Ο ορθοπαιδικός Shane Shapiro στην Mayo Clinic επεξηγεί την θεραπεία για την οστεοαρθρίτιδα μέσο βλαστοκυττάρων από συμπύκνωμα μυελού οστών (BMAC).

Σάββατο 1 Αυγούστου 2015

Συγκριτική υπέροχη μιας έγχυσης PRP σε σύγκριση με μια έγχυση κορτιζόνης για την οστεοαρθρίτιδα του γονάτου.

J Sports Med Phys Fitness. 2015 Jul 14. [Epub ahead of print]

Effect of single injection of Platelet-Rich Plasma in comparison with
corticosteroid on knee osteoarthritis: a double-blind randomized clinical trial.

Forogh B(1), Mianehsaz E, Shoaee S, Ahadi T, Raissi GR, Sajadi S.

Author information: 
(1)Firouzgar Hospital, Physical Medicine and Rehabilitation Department, Iran
University ofMedical Sciences, Tehran, Iran - grezaraissi@yahoo.com.
AIM: Evidence on the effect of Platelet-Rich Plasma (PRP) in treating
osteoarthritis (OA) is insufficient. Therefore, the present study compares the
effects of a one-time injection of PRP and corticosteroid (CS) as two types of
treatment for the patients suffering from osteoarthritis.
METHODS: In the present randomized double blind clinical trial, the participants 
who suffered from knee osteoarthritis (Grades II/III), were randomly divided into
two groups: intra articular injection of PRP and CS. Knee injury and
osteoarthritis outcome score (KOOS), the 20-meter-walk test, active and passive
ranges of motions (ROM), flexion contracture, and pain intensity based on Visual 
Analog Scale (VAS) were assessed before, 2-months, and 6-months after
interventions.
RESULTS: 41 participants (48 knees) were involved in the research (66.7% women;
average age of 61.1±7.0 years old). Compared to the group treated with
corticosteroid, pain relief (df:6 ,35 ;F=11.0 ;p=0.007), symptom free (df:6 ,35
;F=23.0 ;p<0.001), activities of daily living (ADL) (df:6 ,35 ;F=10.7 ;p=0.005)
and quality of life (df:6 ,35 ;F=5.2 ;p=0.02) in the RPR group were significantly
higher, but sporting ability was not different between the 2 groups (df:6 ,35
;F=0.6 ;p=0.55). PRP prescription was significantly more helpful for relieving
patients' pain (VAS) compared to corticosteroids (df:6,35;F=32.0 ;p,0.001).It's
also notable that using PRP was more helpful in improving the 20-meter-walk test 
than corticosteroid treatment (df:6 ,35 ;F=7.4 ;p=0.04) but none of the
treatments had any impact on active flexion ROM ،passive flexion ROM and flexion 
contracture (p>0.05).
CONCLUSION: Our study demonstrated that one shot of PRP injection, decreased
joint pain more and longer-term, alleviated the symptoms, and enhanced the
activity of daily living and quality of life in short-term duration in comparison
with CS.

PMID: 26173792  [PubMed - as supplied by publisher]